Identifying how enzymes stabilize high-energy species along the reaction pathway is central to explaining their enormous rate acceleration. ␤-Phosphoglucomutase catalyses the isomerization of ␤-glucose-1-phosphate to ␤-glucose-6-phosphate and appeared to be unique in its ability to stabilize a high-energy pentacoordinate phosphorane intermediate sufficiently to be directly observable in the enzyme active site. Using 19 F-NMR and kinetic analysis, we report that the complex that forms is not the postulated high-energy reaction intermediate, but a deceptively similar transition state analogue in which MgF 3 ؊ mimics the transferring PO 3 ؊ moiety. Here we present a detailed characterization of the metal ion-fluoride complex bound to the enzyme active site in solution, which reveals the molecular mechanism for fluoride inhibition of ␤-phosphoglucomutase. This NMR methodology has a general application in identifying specific interactions between fluoride complexes and proteins and resolving structural assignments that are indistinguishable by x-ray crystallography.
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enzyme mechanism ͉ fluoride inhibition ͉ NMR structure ͉ phosphoryl transfer ͉ isosteric isoelectronic ͉ transition state analogue P hosphate transfer reactions play a central role in metabolism, regulation, energy housekeeping and signaling (1) . As phosphate esters are kinetically extremely stable, efficient catalysis is crucial for the control of these cellular processes. Although model studies have taught us much about the intrinsic chemical mechanisms (2) , our understanding of the origins of the enormous enzymatic rate accelerations involved, up to a factor of 10 21 (3) , is far from complete (4) . A snapshot of an enzyme in a high-energy state would be immensely useful, as it would allow the very interactions that bring about catalysis to be observed (5) . However, is this realistic given how elusive high-energy intermediates and transition states (TSs) inevitably are? The direct observation of TSs for simple organic reactions has required ultrafast lasers with femtosecond resolution (6) and no physical or spectroscopic method is available to observe the structure of TSs of enzymatic reactions directly. Thus transition state analogues that bind tightly in an enzyme active site have been of paramount importance in defining the structural and energetic framework for catalysis (7, 8) .
An observation that appears to challenge this paradigm arises from structural studies with ␤-phosphoglucomutase (␤-PGM, EC 5.4.2.6): namely, that a high-energy phosphorane on the reaction pathway has been observed directly by x-ray crystallography, demonstrating how the enzyme interacts with a very high-energy, metastable species (9) . The latter also apparently demonstrated that the enzyme catalyzed reaction proceeds through an addition-elimination mechanism, a reaction pathway not observed in solution for phosphate monoester anions. However, the observation of an enzyme "caught in the act" is surprising: the demands of turnover mean that the enzyme would gain no apparent advantage in evolving to stabilize such a high energy intermediate to the extent that it is more stable than the enzyme-product complex. The evolutionary driving force for catalysis is to stabilize the transition states for the formation and breakdown of any such intermediate, and very short lifetimes are expected for any high-energy intermediate.
␤-PGM is a member of the haloalkanoic dehalogenase superfamily, and catalyses the relocation of a phosphate group on glucose in a ping-pong mechanism as shown in Fig. 1 (10) . The physiological substrate ␤-glucose-1-phosphate (␤-G1P) accepts a phosphate group from the phosphoenzyme (␤-PGM*) to give the intermediate, ␤-glucose-1,6-bisphosphate (␤-G16BP), which is dephosphorylated to yield the final product, glucose-6-phosphate (G6P). This reaction has an equilibrium constant of 28, which lies in favor of G6P (11) . The active site cleft, containing a coordinated magnesium ion cofactor, is formed at the interface of the helical cap domain and the ␣͞␤ core domain. If ␤-PGM is crystallized in the presence of ␤-G1P or G6P a pentacoordinate species can be observed by x-ray analysis, and it is this that has been interpreted as a high-energy metastable intermediate (INT) on the reaction pathway, closely related to the TS (9) .
However, this interpretation is not unique. The electron density map is also consistent with a TS analogue (TSA) formed from a five-coordinate magnesium surrounded by two oxygen and three fluoride ligands (MgF 3 -TSA) that mimics the phosphoryl group in flight (12, 13) . The crystallization buffer needs to contain magnesium and fluoride ions for crystals to form (14, 15) , so all of the components necessary for the formation of the MgF 3 -TSA are available. Furthermore, ab initio quantummechanical calculations indicate that MgF 3 -TSA is stable, whereas INT is not and spontaneously rearranges to a phosphate monoester covalently bound to either the substrate or the enzyme, as would be expected of a transition state (16) . This reassignment would account for the long bond lengths around the central atom (they are typical coordinate bond lengths) and would also remove the requirement that the hitherto unobserved trianionic phosphorane INT be stable for several days at 18°C for crystallization (9, 17) . We have probed the identity of the pentacoordinate species by using NMR methodology and kinetic analysis to establish whether MgF 3 Ϫ , which cannot readily be observed in solution, can form in an enzyme active site as an isoelectronic and isosteric mimic of PO 3 Ϫ .
Results
We expressed and purified ␤-PGM according to published procedures (9, 17, 18) . Like the related ␣-PGM enzyme (19), ␤-PGM had been postulated to be in its phosphorylated form (␤-PGM*) when isolated (18) , but electrospray massspectrometric analysis only shows a peak at 24,207.8 Ϯ 1.8 Da corresponding to the predicted mass of unphosphorylated ␤-PGM (Supporting Text and Fig. 6 , which are published as supporting information on the PNAS web site). This is to be expected from the estimated half-life of a carboxyl phosphate (t 1/2 Ϸ 20 h) for acetylphosphate (20) and is consistent with more recent data on ␤-PGM (10), but differs from the original report (9) . However, ␤-PGM also exhibits phosphodismutase activity so the enzyme does not need to be initially phosphorylated nor require the addition of the bisphosphorylated intermediate for mutase activity. Phosphorylation of ␤-PGM by the substrate itself can generate ␤-PGM* (10) to initiate the catalytic cycle.
Initial NMR experiments confirmed the lack of phosphate in the native enzyme by showing no signal for phosphorus in the 31 P NMR spectrum. We then added ␤-G1P (5 mM) to ␤-PGM (1 mM) to see whether we could directly detect the proposed phosphorane intermediate using 31 P NMR. However, we only observed full turnover of ␤-G1P (␦ 31 P 3.00 ppm) into G6P (␦ 31 P 4.95 and 5.02 ppm for ␣ and ␤ anomers, respectively) within the dead time of the experiment followed by slower hydrolysis over a few hours to leave inorganic phosphate (␦ 31 P 2.62 ppm) as the final product. Hence, there is no evidence for an accumulation of an enzyme bound phosphorane in solution. On the other hand, in the presence of fluoride and G6P, a new 31 P resonance corresponding to a phosphate was observed (␦ 31 P 5.75 ppm). This signal remained unchanged over at least 2 months, and possessed a 1:1 stoichiometry to the enzyme concentration and a line-width appropriate for an enzyme-bound ligand.
We then used 19 F NMR spectroscopy to establish whether the pentacoordinate species could be MgF 3 -TSA, i.e., whether fluoride is present in the G6P͞␤-PGM complex. This approach allows us to distinguish MgF 3 Ϫ from the central PO 3 Ϫ moiety in INT unambiguously. When ␤-PGM is added to a solution containing MgCl 2 and a 10-fold excess of NH 4 F, 19 F resonances are observed for free fluoride and for MgF ϩ in solution. As soon as either ␤-G1P or G6P are added, three intense new 19 F resonances appear (Fig. 2) , each with a 1:1 stoichiometry with the enzyme concentration. When substoichiometric concentrations of fluoride are added into the G6P͞␤-PGM system, the three 19 F resonances appear simultaneously in a 1:1:1 ratio. (Fig. 3 ), corresponding to a transition from an open to a closed conformation (10) . NMR resonance assignment of uniformly 2 H, 13 C, 15 N-labeled ␤-PGM both in the open conformation and in the G6P͞␤-PGM complex was achieved by using methods described in ref. 21 . The regions of ␤-PGM exhibiting the largest chemical shift changes correspond to those residues which comprise the active site loops, or else residues located in the ''hinge'' region between the ''cap'' and ''core'' domains (10) . These NMR observations are consistent with the suggestion that these domains move as rigid bodies relative to each other to enclose the substrate (10). (Table 1 , which is published as supporting information on the PNAS web site). These were used as restraints to move three fluoride ions into the closed conformation of ␤-PGM (Protein Data Bank ID code 1O08) from random starting coordinates by using standard solution structure determination procedures within the program CNS (22) . The resulting positional distribution of fluoride ions (Fig. 4) places them as predicted for the MgF 3 -TSA interpretation of the x-ray structural data (9, 12) . The new enzyme-bound 31 P resonance therefore arises from the phosphate group of G6P when bound to the enzyme (Fig. 4) . The combined NMR data show clearly that in the presence of millimolar concentrations of fluoride, the major species present in solution on addition of substrate or product to ␤-PGM is MgF 3 -TSA.
The trigonal-planar MgF 3 Ϫ moiety in MgF 3 -TSA serves as a mimic for PO 3 Ϫ ; if this is a good model of the TS, the enzyme should be efficiently inhibited. Fig. 5 shows that under the crystallization (9, 17) and NMR conditions, the reaction is clearly inhibited by fluoride with an apparent K i in the low mM range. This observation appears to contradict previous reports that ␤-PGM is not inhibited by added fluoride (14, 15) . We note However, no data were obtained for residues in the active site loops (D8 -T16, L44 -L53, S114 -N118, V141-A142, and S171-Q172) in the open conformation, because the corresponding 15 N-TROSY peaks were broadened beyond the limits of detection. This line-broadening behavior is indicative of a conformational dynamics process between two (or more) similarly populated forms, and the difference in 1 H chemical shift of Ϸ2 ppm between these interconverting conformations equates to conformational dynamics occurring in the millisecond timescale (i.e., dynamics in the intermediate exchange regime for 1 H). These residues are depicted with open bars. Further significant ⌬␦ involve residues A17-Q43 positioned in two ␣-helices of the ''cap'' domain and N77-S88, which locate to the C-terminal portion of the S65-I84 ␣-helix and the ''hinge'' region (Q85-Y93). For the remainder of ␤-PGM, small ⌬␦ indicate that, on formation of MgF3-TSA, there is little change in the local protein fold outside of these regions. that kinetic assays of ␣-and ␤-PGM are usually run in the presence of either ␣-or ␤-G16BP, which accelerate the reaction by saturating the enzyme at the intermediate stage or maintaining its activated, phosphorylated state (10, 15, 19) . Only ␤-G16BP can contribute by maintaining a high concentration of the ␤-G16BP͞␤-PGM complex, but other cofactors can stimulate the enzyme by acting as phosphorylating agents, and commercially available ␣-G16BP is used commonly (10, (23) (24) (25) . Interestingly ␣-G16BP is not turned over to G6P by ␤-PGM, but is converted to ␣-G1P to generate ␤-PGM* (10) . If the cofactors ␣-or ␤-G16BP are used at low concentrations, the enzymatic reaction is still clearly inhibited by fluoride with a similar apparent K i (Fig. 5) . However, the published inhibition study was conducted under the unusual conditions of a 2-fold excess of intermediate ␤-G16BP (200 M) to substrate ␤-G1P (100 M) (15). When we repeated our experiments in the presence of high concentrations of ␤-G16BP, we also observed that even 10 mM fluoride did not inhibit the reaction (Fig. 5) . Under these conditions, pre-steady-state kinetics with ␤-PGM and ␤-G16BP show a burst of product G6P release followed by steady-state hydrolysis of phosphoenzyme (data not shown), which indicates that high concentrations of ␤-G16BP maintain ␤-PGM in a phosphorylated state. With the enzyme phosphorylated on the nucleophilic aspartate, MgF 3 -TSA simply cannot form.
Discussion
All of the structural and kinetic observations described above, and the previous x-ray data, are consistent with the formation of MgF 3 -TSA when G6P, magnesium, and fluoride are present with ␤-PGM. Reassigning the pentacoordinate species as a transition state analogue necessarily limits the inferences that can be drawn from the structure as the bond lengths and electrostatic contacts will be governed by the intrinsic ground state properties of the analogue, and thus do not necessarily reflect the bond lengths in the TS or potential INT. However, the central MgF 3 Ϫ moiety is both isoelectronic and isosteric with metaphosphate PO 3 Ϫ and so provides a closer portrayal of the expanded TS for phosphate monoester transfer in solution than aluminum and beryllium fluoride complexes which have been more widely utilized to date (13, (26) (27) (28) . The intrinsic binding constant of MgF 3 Ϫ to the enzyme-substrate complex will be considerably lower than the observed K i as MgF 3 Ϫ has a very low formation constant in aqueous solution [MgF ϩ has log ␤ 1 ϭ 1.7 and MgF 2 has log ␤ 2 Յ 3.2 (29); MgF 3 Ϫ has not been observed in solution], which means that it is only observable in the enzyme active site. This low solution stability suggests that magnesium trifluoride will be a sensitive probe for identifying active sites that strongly stabilize such trigonal-bipyramidal species with a similar charge distribution, because productive interactions with the enzyme pocket are required for assembly of the transition state analogue. Consistent with this expectation, the simultaneous appearance of the fluoride resonances in the same ratio as the final complex together with a concomitant transition of ␤-PGM from the open to closed conformation on titration of the G6P͞␤-PGM system with fluoride is conclusive evidence that MgF 3 -TSA assembles cooperatively and is stoichiometric with ␤-PGM concentration.
These observations have broad implications for understanding the basis of and potential for fluoride inhibition of enzymes that catalyze phosphoryl transfer in the presence of magnesium ions. Fluoride inhibition of certain enzymes has been linked to its mammalian toxicity and to its therapeutic action in dental health. The growth of Treponema, Actinomyces, Fusobacterium, and Bacteroides species is inhibited by millimolar concentrations of fluoride and this has been linked to fluoride inhibition of acid and alkaline phosphatases (30) . The proton translocating enzyme F o ATPases of oral bacteria are also inhibited by fluoride at millimolar concentration (31) . In general, such fluoride inhibition has been attributed to the replacement of an essential water or hydroxide ion in the active complex by fluoride (32), but it is likely that formation of MgF 3 Ϫ in the active site may be the true inhibitor in some cases; and it may be particularly important in affecting the most proficient enzymes which have exceptionally strong formal transition state affinities (3, 7) .
Here, we present a detailed characterization of a metal ion-fluoride complex bound to an enzyme active site in solution, and reveal the molecular mechanism for fluoride inhibition of ␤-PGM. These results show that it is possible for fluoride ions to be located in an enzyme-analogue complex in solution with high structural accuracy. Hence, MgF 3 -TSA has the potential to allow us to define the solution structure of the active site as it is arranged around a mimic for the transferring phosphoryl moiety. The high susceptibility of 19 F NMR chemical shifts to the local electronic environment provides a sensitive probe of subtle changes within the enzyme that would be invisible to other structural biology methods. These methods can also be applied to the study of other complexes that contain metal-fluoride species as analogues for phosphates, such as aluminum (27, 33) and beryllium (26, 34) fluorides, and will enable the accurate assignment of their identity in future. The potential utility of using fluoride as a probe of enzyme structure is especially powerful when used in combination with an electronically and geometrically accurate transition state mimic for phosphoryl transfer, MgF 3 Ϫ , that only exists within the confines of the active site and places the spectroscopically active atoms right into the catalytic cavity.
Materials and Methods
Expression and Purification of ␤-PGM. The ␤-PGM gene was amplified from a Lactococcus lactis strain obtained from DSMZ (Braunschweig, Germany) (no. 20481, which is identical to ATCC strain 19435). This strain was grown at 30°C on plates with corynebacterium agar containing casein peptone tryptic digest (10 g), yeast extract (5 g), glucose (5 g), NaCl (5 g), agar (15 g), and distilled water (1,000 ml) adjusted to pH 7.2-7.4. A toothpick-scrape of a colony was used as a template in a PCR to amplify the gene. Primers (5Ј-GAA TTC CAT ATG TTT AAA GCA GTA TTG-3Ј and 5Ј-CCG CTC GAG TTA TTT TTG CTT TTG AAG-3Ј) were used to introduce a NdeI and a XhoI restriction site at the beginning and end of the gene, respectively. After digestion, the PCR product was cloned in the pET-22b(ϩ) expression vector (Novagen, San Diego, CA) giving the expected published sequence (35) . Transformed Escherichia coli BL21(DE3) with this plasmid were used to overexpress ␤-PGM. The expression and purification of the protein were carried out exactly as described in ref. 17 . 15 N-HSQC spectra were obtained by subtracting the spectra recorded with defined 19 F irradiation frequencies from the off-resonance spectrum. For the backbone resonance assignment of ␤-PGM in MgF 3 -TSA, NMR spectra were acquired at 25°C on a sample of 2 H, 15 N, 13 C-labeled ␤-PGM (sample prepared as above except with 20 mM G6P) using a Bruker Avance 600 MHz spectrometer equipped with a 5-mm 1 H͞ 15 N͞ 13 C͞ 2 H cryoprobe and pulse-field z-gradients. Backbone resonance assignments for HN, N, C ␣ , C ␤ , and CЈ nuclei were obtained from 2D 15 N-TROSY, 3D TROSY ct-HNCA, 3D TROSY ct-HN(CO)CA, 3D TROSY HN(CA)CB, 3D TROSY HN(COCA)CB, 3D TROSY HN(CA)CO, and 3D TROSY HNCO. The data were acquired, processed, and analyzed and backbone sequential assignment was performed as in ref. 21 . Backbone sequential assignment of ␤-PGM in the open conformation was performed as for ␤-PGM in MgF 3 -TSA using a sample containing 1 mM ␤-PGM, 5 mM MgCl 2 , and 10 mM NH 4 ␤-PGM Kinetic Assays. All ␤-PGM assays were carried out in a Molecular Devices (Sunnyvale, CA) Microtitreplate Spectramax Plus Reader at 25°C in 50 mM K ϩ Hepes (pH 7.2) with 100 l total volume containing 2 mM MgCl 2 and 5 nM ␤-PGM unless stated otherwise. All substrates were obtained commercially from Fluka (St. Louis, MO) and Sigma (St. Louis, MO) except for ␤-G16BP which was synthesized from ␣-Dglucose (Scheme 1, which is published as supporting information on the PNAS web site). Enzyme concentrations were measured by using 280 ϭ 20.6 M Ϫ1 ⅐cm Ϫ1 determined by the Biuret method (36) with commercial BSA standards (Sigma) used for the calibration. The appearance of G6P was monitored in a coupled assay with glucose-6-phosphate dehydrogenase (obtained from Sigma, 5 units͞ml G6PDH and 0.5 mM NAD ϩ ) following the absorbance at 340 nm. Reactions were initiated by the addition of the substrate. The steady-state rates were calculated from the linear portions of time courses and when less than 20% of substrate was converted. Fluoride inhibition of glucose-6-phosphate dehydrogenase could not be detected below 100 mM in our experimental setup. Any inhibitory effects can therefore be ascribed to effects on ␤-PGM alone.
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